Risperidone Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Start your free 7-Day Trial! Book a demo to explore our global patent data.

It is formulated by 21 pharmaceutical companies such as RATIOPHARM, PRECISION DOSE, SUN PHARM INDS LTD and others. It is marketed under 5 brand names, including RISPERIDONE, PERSERIS KIT, RYKINDO and others. Available in 26 different strengths, such as 2MG, 0.25MG, 3MG and others, and administered through 7 routes including TABLET;ORAL, SOLUTION;ORAL, TABLET, ORALLY DISINTEGRATING;ORAL and others.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 21 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...
watch_later Watch: autorenew Loading watch analysis...
rocket_launch Opportunity: autorenew Loading opportunity analysis...
flag
gavel
calendar_today
calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patents

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
✓ Latest exclusivity data and extensions
Unlock Global Access

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patent Timeline

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength Route of Administration Companies Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

Patent Number Publication Date Legal Status Patent Expiry Date
{"application_id":"112721","ingredient":"RISPERIDONE","trade_name":"UZEDY","family_id":"b8595f22f4ff44a98433","publication_number":"US10736965B2","cleaned_patent_number":"10736965","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-01-12","publication_date":"2020-08-11","legal_status":"Expired"} US10736965B2 Formulation 11 Aug, 2020 Expired 12 Jan, 2025
{"application_id":"112718","ingredient":"RISPERIDONE","trade_name":"UZEDY","family_id":"b8595f22f4ff44a98433","publication_number":"US9895447B2","cleaned_patent_number":"9895447","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-01-12","publication_date":"2018-02-20","legal_status":"Granted"} US9895447B2 Formulation 20 Feb, 2018 Granted 12 Jan, 2025
{"application_id":"112717","ingredient":"RISPERIDONE","trade_name":"UZEDY","family_id":"b8595f22f4ff44a98433","publication_number":"US9717799B2","cleaned_patent_number":"9717799","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-01-12","publication_date":"2017-08-01","legal_status":"Granted"} US9717799B2 Formulation 01 Aug, 2017 Granted 12 Jan, 2025
{"application_id":"112693","ingredient":"RISPERIDONE","trade_name":"UZEDY","family_id":"b8595f22f4ff44a98433","publication_number":"US9439905B2","cleaned_patent_number":"9439905","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-01-12","publication_date":"2016-09-13","legal_status":"Granted"} US9439905B2 Formulation 13 Sep, 2016 Granted 12 Jan, 2025
{"application_id":"112716","ingredient":"RISPERIDONE","trade_name":"UZEDY","family_id":"b8595f22f4ff44a98433","publication_number":"US8802127B2","cleaned_patent_number":"8802127","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-01-12","publication_date":"2014-08-12","legal_status":"Granted"} US8802127B2 Formulation 12 Aug, 2014 Granted 12 Jan, 2025
{"application_id":"112719","ingredient":"RISPERIDONE","trade_name":"UZEDY","family_id":"b8595f22f4ff44a98433","publication_number":"US9925268B2","cleaned_patent_number":"9925268","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-01-12","publication_date":"2018-03-27","legal_status":"Granted"} US9925268B2 Formulation 27 Mar, 2018 Granted 12 Jan, 2025
{"application_id":"58076","ingredient":"RISPERIDONE","trade_name":"PERSERIS KIT","family_id":"8d5752d25c4d45a09c44","publication_number":"US10406160B2","cleaned_patent_number":"10406160","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-06-26","publication_date":"2019-09-10","legal_status":"Granted"} US10406160B2 Formulation 10 Sep, 2019 Granted 26 Jun, 2026
{"application_id":"58055","ingredient":"RISPERIDONE","trade_name":"PERSERIS KIT","family_id":"8d5752d25c4d45a09c44","publication_number":"US10058554B2","cleaned_patent_number":"10058554","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-09-26","publication_date":"2018-08-28","legal_status":"Granted"} US10058554B2 28 Aug, 2018 Granted 26 Sep, 2026
{"application_id":"58075","ingredient":"RISPERIDONE","trade_name":"PERSERIS KIT","family_id":"8d5752d25c4d45a09c44","publication_number":"US9597402B2","cleaned_patent_number":"9597402","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-09-26","publication_date":"2017-03-21","legal_status":"Granted"} US9597402B2 Formulation 21 Mar, 2017 Granted 26 Sep, 2026
{"application_id":"58077","ingredient":"RISPERIDONE","trade_name":"PERSERIS KIT","family_id":"8d5752d25c4d45a09c44","publication_number":"US11110093B2","cleaned_patent_number":"11110093","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-11-05","publication_date":"2021-09-07","legal_status":"Granted"} US11110093B2 Formulation 07 Sep, 2021 Granted 05 Nov, 2026
{"application_id":"112715","ingredient":"RISPERIDONE","trade_name":"UZEDY","family_id":"b8595f22f4ff44a98433","publication_number":"US8741327B2","cleaned_patent_number":"8741327","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-11-12","publication_date":"2014-06-03","legal_status":"Granted"} US8741327B2 Formulation 03 Jun, 2014 Granted 12 Nov, 2027
{"application_id":"112713","ingredient":"RISPERIDONE","trade_name":"UZEDY","family_id":"b8595f22f4ff44a98433","publication_number":"US8221778B2","cleaned_patent_number":"8221778","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-11-12","publication_date":"2012-07-17","legal_status":"Granted"} US8221778B2 Formulation 17 Jul, 2012 Granted 12 Nov, 2027
{"application_id":"58049","ingredient":"RISPERIDONE","trade_name":"PERSERIS KIT","family_id":"28bdff29262043d1a210","publication_number":"US10010612B2","cleaned_patent_number":"10010612","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2028-02-13","publication_date":"2018-07-03","legal_status":"Patented case"} US10010612B2 Formulation 03 Jul, 2018 Patented case 13 Feb, 2028
{"application_id":"58050","ingredient":"RISPERIDONE","trade_name":"PERSERIS KIT","family_id":"28bdff29262043d1a210","publication_number":"US10376590B2","cleaned_patent_number":"10376590","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2028-02-13","publication_date":"2019-08-13","legal_status":"Granted"} US10376590B2 13 Aug, 2019 Granted 13 Feb, 2028
{"application_id":"58051","ingredient":"RISPERIDONE","trade_name":"PERSERIS KIT","family_id":"28bdff29262043d1a210","publication_number":"US11013809B2","cleaned_patent_number":"11013809","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2028-02-13","publication_date":"2021-05-25","legal_status":"Granted"} US11013809B2 Formulation 25 May, 2021 Granted 13 Feb, 2028
{"application_id":"115124","ingredient":"RISPERIDONE","trade_name":"PERSERIS KIT","family_id":"28bdff29262043d1a210","publication_number":"US11712475B2","cleaned_patent_number":"11712475","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2028-02-13","publication_date":"2023-08-01","legal_status":"Granted"} US11712475B2 01 Aug, 2023 Granted 13 Feb, 2028
{"application_id":"58048","ingredient":"RISPERIDONE","trade_name":"PERSERIS KIT","family_id":"28bdff29262043d1a210","publication_number":"US9180197B2","cleaned_patent_number":"9180197","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2028-02-13","publication_date":"2015-11-10","legal_status":"Granted"} US9180197B2 Formulation 10 Nov, 2015 Granted 13 Feb, 2028
{"application_id":"58032","ingredient":"RISPERIDONE","trade_name":"PERSERIS KIT","family_id":"28bdff29262043d1a210","publication_number":"US9186413B2","cleaned_patent_number":"9186413","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2028-02-13","publication_date":"2015-11-17","legal_status":"Granted"} US9186413B2 17 Nov, 2015 Granted 13 Feb, 2028
{"application_id":"123441","ingredient":"RISPERIDONE","trade_name":"RISVAN","family_id":"","publication_number":"US11173110B2","cleaned_patent_number":"11173110","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-05-31","publication_date":"2021-11-16","legal_status":"Granted"} US11173110B2 16 Nov, 2021 Granted 31 May, 2031
{"application_id":"123440","ingredient":"RISPERIDONE","trade_name":"RISVAN","family_id":"","publication_number":"US11241377B2","cleaned_patent_number":"11241377","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-05-31","publication_date":"2022-02-08","legal_status":"Granted"} US11241377B2 08 Feb, 2022 Granted 31 May, 2031
{"application_id":"123451","ingredient":"RISPERIDONE","trade_name":"RISVAN","family_id":"","publication_number":"US10335366B2","cleaned_patent_number":"10335366","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-05-31","publication_date":"2019-07-02","legal_status":"Granted"} US10335366B2 Formulation 02 Jul, 2019 Granted 31 May, 2031
{"application_id":"123446","ingredient":"RISPERIDONE","trade_name":"RISVAN","family_id":"","publication_number":"US10085936B2","cleaned_patent_number":"10085936","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-05-31","publication_date":"2018-10-02","legal_status":"Granted"} US10085936B2 Formulation 02 Oct, 2018 Granted 31 May, 2031
{"application_id":"123448","ingredient":"RISPERIDONE","trade_name":"RISVAN","family_id":"","publication_number":"US10058504B2","cleaned_patent_number":"10058504","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-05-31","publication_date":"2018-08-28","legal_status":"Granted"} US10058504B2 Formulation 28 Aug, 2018 Granted 31 May, 2031
{"application_id":"123443","ingredient":"RISPERIDONE","trade_name":"RISVAN","family_id":"","publication_number":"US10195138B2","cleaned_patent_number":"10195138","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-05-31","publication_date":"2019-02-05","legal_status":"Granted"} US10195138B2 05 Feb, 2019 Granted 31 May, 2031
{"application_id":"123442","ingredient":"RISPERIDONE","trade_name":"RISVAN","family_id":"","publication_number":"US11007139B2","cleaned_patent_number":"11007139","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-05-31","publication_date":"2021-05-18","legal_status":"Granted"} US11007139B2 18 May, 2021 Granted 31 May, 2031
{"application_id":"123444","ingredient":"RISPERIDONE","trade_name":"RISVAN","family_id":"","publication_number":"US10182982B2","cleaned_patent_number":"10182982","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-05-31","publication_date":"2019-01-22","legal_status":"Granted"} US10182982B2 22 Jan, 2019 Granted 31 May, 2031
{"application_id":"123447","ingredient":"RISPERIDONE","trade_name":"RISVAN","family_id":"","publication_number":"US10881605B2","cleaned_patent_number":"10881605","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-05-31","publication_date":"2021-01-05","legal_status":"Granted"} US10881605B2 Formulation 05 Jan, 2021 Granted 31 May, 2031
{"application_id":"123439","ingredient":"RISPERIDONE","trade_name":"RISVAN","family_id":"","publication_number":"US11752092B2","cleaned_patent_number":"11752092","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-05-31","publication_date":"2023-09-12","legal_status":"Granted"} US11752092B2 12 Sep, 2023 Granted 31 May, 2031
{"application_id":"123450","ingredient":"RISPERIDONE","trade_name":"RISVAN","family_id":"","publication_number":"US11752093B2","cleaned_patent_number":"11752093","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-05-31","publication_date":"2023-09-12","legal_status":"Granted"} US11752093B2 Formulation 12 Sep, 2023 Granted 31 May, 2031
{"application_id":"124056","ingredient":"RISPERIDONE","trade_name":"RISVAN","family_id":"","publication_number":"US11752094B2","cleaned_patent_number":"11752094","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-05-31","publication_date":"2023-09-12","legal_status":"Granted"} US11752094B2 12 Sep, 2023 Granted 31 May, 2031
{"application_id":"123445","ingredient":"RISPERIDONE","trade_name":"RISVAN","family_id":"","publication_number":"US11759416B2","cleaned_patent_number":"11759416","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-05-31","publication_date":"2023-09-19","legal_status":"Granted"} US11759416B2 19 Sep, 2023 Granted 31 May, 2031
{"application_id":"123449","ingredient":"RISPERIDONE","trade_name":"RISVAN","family_id":"","publication_number":"US10463607B2","cleaned_patent_number":"10463607","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-05-31","publication_date":"2019-11-05","legal_status":"Granted"} US10463607B2 Formulation 05 Nov, 2019 Granted 31 May, 2031
{"application_id":"110439","ingredient":"RISPERIDONE","trade_name":"RYKINDO","family_id":"c788d8dd478a4f28a93f","publication_number":"US9532991B2","cleaned_patent_number":"9532991","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-04-10","publication_date":"2017-01-03","legal_status":"Granted"} US9532991B2 Formulation 03 Jan, 2017 Granted 10 Apr, 2032
{"application_id":"110410","ingredient":"RISPERIDONE","trade_name":"RYKINDO","family_id":"c788d8dd478a4f28a93f","publication_number":"US10406161B2","cleaned_patent_number":"10406161","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-04-10","publication_date":"2019-09-10","legal_status":"Granted"} US10406161B2 Formulation 10 Sep, 2019 Granted 10 Apr, 2032
{"application_id":"110441","ingredient":"RISPERIDONE","trade_name":"RYKINDO","family_id":"c788d8dd478a4f28a93f","publication_number":"US11110094B2","cleaned_patent_number":"11110094","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-04-10","publication_date":"2021-09-07","legal_status":"Granted"} US11110094B2 Formulation 07 Sep, 2021 Granted 10 Apr, 2032
{"application_id":"110440","ingredient":"RISPERIDONE","trade_name":"RYKINDO","family_id":"c788d8dd478a4f28a93f","publication_number":"US10098882B2","cleaned_patent_number":"10098882","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-04-10","publication_date":"2018-10-16","legal_status":"Granted"} US10098882B2 Formulation 16 Oct, 2018 Granted 10 Apr, 2032
{"application_id":"110438","ingredient":"RISPERIDONE","trade_name":"RYKINDO","family_id":"c788d8dd478a4f28a93f","publication_number":"US9446135B2","cleaned_patent_number":"9446135","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-04-10","publication_date":"2016-09-20","legal_status":"Granted"} US9446135B2 Formulation 20 Sep, 2016 Granted 10 Apr, 2032
{"application_id":"116297","ingredient":"RISPERIDONE","trade_name":"UZEDY","family_id":"c71377003a1d48a0ab05","publication_number":"US9023897B2","cleaned_patent_number":"9023897","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-04-05","publication_date":"2015-05-05","legal_status":"Granted"} US9023897B2 Formulation 05 May, 2015 Granted 05 Apr, 2033
{"application_id":"138512","ingredient":"RISPERIDONE","trade_name":"UZEDY","family_id":"","publication_number":"US12128132B2","cleaned_patent_number":"12128132","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2040-09-11","publication_date":"2024-10-29","legal_status":"Granted"} US12128132B2 Formulation 29 Oct, 2024 Granted 11 Sep, 2040

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID Title Status Phase Conditions Start Date Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

View Complete Supplier List

Unlock access to all suppliers of Risperidone

✓ Access a comprehensive list of global suppliers
✓ Get information on each supplier
Unlock Suppliers

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.

GreyB © 2025 Elixir. All rights reserved.